Thomas Renaud
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 34
- Multiple Myeloma Research and Treatments 30
- Oncology 19
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- Florence Jusot (4 shared papers)Tara Masterson (21 shared papers)Brandi Hilder (20 shared papers)Jaszianne Tolbert (22 shared papers)Josselin Thuilliez (4 shared papers)Rachel Kobos (7 shared papers)Andrew Street (3 shared papers)Christoph Heuck (18 shared papers)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (5 papers)Health Economics (3 papers)British Journal of Haematology (2 papers)Social Science & Medicine (2 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Thomas Renaud
63 papers receiving 707 citations
Thomas Renaud's Hit Papers
Peers
Comparison fields: 5 of 80
- Hematology 282
- Oncology 221
- Applied Microbiology and Biotechnology 9
- Radiology, Nuclear Medicine and Imaging 103
- General Health Professions 92
Countries citing papers authored by Thomas Renaud
This map shows the geographic impact of Thomas Renaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Renaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Renaud more than expected).
Fields of papers citing papers by Thomas Renaud
This network shows the impact of papers produced by Thomas Renaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Renaud. The network helps show where Thomas Renaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Renaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 64 | |
| 2 | GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review Hit paper breakdown → | 2024 | 63 |
| 3 | 2012 | 49 | |
| 4 | 2021 | 49 | |
| 5 | 2023 | 32 | |
| 6 | 2023 | 31 | |
| 7 | 2013 | 31 | |
| 8 | 2000 | 29 | |
| 9 | 2019 | 28 | |
| 10 | 2011 | 27 | |
| 11 | 2008 | 27 | |
| 12 | 2013 | 25 | |
| 13 | 2010 | 23 | |
| 14 | 2024 | 22 | |
| 15 | 2023 | 16 | |
| 16 | 2012 | 16 | |
| 17 | 2021 | 15 | |
| 18 | 2022 | 15 | |
| 19 | 2009 | 13 | |
| 20 | 2023 | 12 |
About Thomas Renaud
Thomas Renaud is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, General Health Professions and Economics and Econometrics, having authored 70 papers that have together received 727 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Healthcare Systems and Practices (5 papers), Healthcare Policy and Management (5 papers), HER2/EGFR in Cancer Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Hematology (282 citations), Oncology (221 citations), Applied Microbiology and Biotechnology (9 citations), Radiology, Nuclear Medicine and Imaging (103 citations) and General Health Professions (92 citations). Thomas Renaud has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Florence Jusot, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Josselin Thuilliez, Rachel Kobos, Andrew Street, Christoph Heuck, Michela Campagna and Deeksha Vishwamitra. Their work appears in journals such as Blood, Journal of Clinical Oncology, Health Economics, British Journal of Haematology and Social Science & Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.